What is the brand name for formoterol (Long-Acting Beta Agonist)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brand Name for Formoterol

The brand name for formoterol (a long-acting beta agonist) is Foradil Aerolizer. 1

Formoterol Overview

Formoterol is a selective long-acting beta2-adrenergic receptor agonist (LABA) that provides significant bronchodilation for up to 12 hours following a single dose. It is available under the brand name Foradil Aerolizer as indicated in the FDA drug label 1.

Key Characteristics:

  • Duration of action: More than 12 hours 2
  • Onset of action: Rapid onset (significant bronchodilation within minutes of inhalation) 3
  • Specificity: Very specific for β-adrenergic receptors with low rates of tremor and palpitations 2

Clinical Applications

Formoterol (Foradil) is FDA-approved for:

  1. Asthma treatment:

    • Only as concomitant therapy with a long-term asthma control medication (such as an inhaled corticosteroid)
    • For adults and children 5 years of age and older with reversible obstructive airways disease 1
  2. Exercise-induced bronchospasm (EIB):

    • For acute prevention of EIB in adults and children 5 years and older
    • Can be used on an occasional, as-needed basis 1
  3. Chronic Obstructive Pulmonary Disease (COPD):

    • For long-term, twice daily maintenance treatment of bronchoconstriction
    • Includes patients with chronic bronchitis and emphysema 1

Important Safety Considerations

Black Box Warning

Long-acting beta2-agonists like formoterol increase the risk of asthma-related death. Therefore:

  • Never use formoterol as monotherapy for asthma treatment
  • Always use in combination with a long-term asthma control medication (e.g., inhaled corticosteroid)
  • Once asthma control is achieved, consider stepping down therapy if possible 1

Pediatric and Adolescent Patients

For pediatric and adolescent patients requiring a LABA in addition to an inhaled corticosteroid, a fixed-dose combination product containing both medications is generally preferred to ensure adherence with both components 1.

Formulation and Delivery

Foradil is delivered via the Aerolizer device as a dry powder inhalation 1, 4. A newer formulation called Foradil Certihaler, which utilizes a multidose dry-powder inhaler device, has also been developed 5.

Clinical Differentiation from Other LABAs

When comparing formoterol to salmeterol (another LABA):

  • Formoterol achieves significant bronchodilation more rapidly than salmeterol
  • Both medications have similar duration of bronchodilation (approximately 12 hours) 3, 6

Formoterol is also available as arformoterol (R,R-formoterol), which is a single isomer form of formoterol developed by Sepracor for respiratory disorders 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.